ADMA Biologics Inc. (ADMA)
NASDAQ: ADMA
· Real-Time Price · USD
14.66
0.13 (0.89%)
At close: Oct 03, 2025, 3:59 PM
14.65
-0.07%
After-hours: Oct 03, 2025, 07:52 PM EDT
0.89% (1D)
| Bid | 14.55 |
| Market Cap | 3.5B |
| Revenue (ttm) | 474.17M |
| Net Income (ttm) | 208.93M |
| EPS (ttm) | 0.85 |
| PE Ratio (ttm) | 17.25 |
| Forward PE | 16.33 |
| Analyst | Strong Buy |
| Dividends | n/a |
| Ask | 14.7 |
| Volume | 2,926,404 |
| Avg. Volume (20D) | 3,487,056.1 |
| Open | 14.56 |
| Previous Close | 14.53 |
| Day's Range | 14.48 - 14.89 |
| 52-Week Range | 13.50 - 25.67 |
| Beta | 0.46 |
| Ex-Dividend Date | n/a |
About ADMA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ADMA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ADMA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsADMA Biologics Inc. is scheduled to release its earnings on
Nov 6, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-9.65%
ADMA Biologics shares are trading lower after the ...
Unlock content with
Pro Subscription
1 month ago
-2.22%
ADMA Biologics shares are trading lower after the company reported worse-than-expected Q2 revenue results and issued FY26 revenue guidance below estimates.
1 month ago · seekingalpha.com
ADMA Biologics: Strong Product Mix, Growing Margins And Compelling UpsideADMA Biologics' earnings are surging due to higher plasma yield and a profitable shift toward premium IG brands, boosting margins. FDA approval of yield-enhancement technology increases finished IG ou...
